Crispr Therapeutics shares owned by B & T Capital Management DBA Alpha Capital Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by B & T Capital Management DBA Alpha Capital Management
from 13F filings
Historical chart of B & T Capital Management DBA Alpha Capital Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by B & T Capital Management DBA Alpha Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by B & T Capital Management DBA Alpha Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $3.0M | 44k | 68.16 |
| 2023-12-31 | $2.8M | 45k | 62.60 |
| 2023-09-30 | $2.1M | 46k | 45.39 |
| 2023-06-30 | $1.3M | 33k | 40.65 |
| 2023-03-31 | $1.3M | 33k | 40.65 |
| 2022-12-31 | $1.3M | 33k | 40.65 |
| 2022-09-30 | $2.0M | 30k | 65.34 |
| 2022-06-30 | $1.6M | 27k | 60.77 |
| 2022-03-31 | $1.5M | 23k | 62.77 |
| 2021-12-31 | $1.7M | 23k | 75.78 |
| 2021-09-30 | $2.8M | 25k | 111.93 |
| 2021-06-30 | $4.1M | 26k | 161.90 |
| 2021-03-31 | $1.0M | 8.3k | 121.79 |
| 2020-12-31 | $793k | 5.2k | 153.15 |
More positions owned by B & T Capital Management DBA Alpha Capital Management
View all positions for B & T Capital Management DBA Alpha Capital Management